Literature DB >> 2168190

Local control of operable breast cancer after radiotherapy alone.

E Van Limbergen1, E Van der Schueren, W Van den Bogaert, J Van Wing.   

Abstract

221 patients with operable breast carcinoma stage Tis, T1, T2, T3, N0N1 were treated with radiotherapy alone without tumorectomy. The mean follow-up time was 15.5 years (range 5-22). The annual risk for local recurrence was 3% during the first 5 years and 1% during the following 10 years, resulting in an actuarial local control rate of 75.4% after 15 years. The risk for local recurrence was assessed in multivariate analysis and was significantly related to the size of the tumour measured on mammography (P = 0.0002), the radiation dose administered (P = 0.0018), the length of the split-course intervals being longer than 75 days (P = 0.001) and age (P = 0.019). Dose was related to response over a wide range as a function of tumour volume. All 18 patients with minimal tumour load (T0 and Paget's disease) treated with doses above 55 Gy in 6 weeks achieved local control. 5-year local control rates ranged from 40 to 100% for T1 carcinomas treated with 45-110 Gy, and from 0 to 95.3% for T2 carcinomas at the same dose. For T3 carcinomas local control varied between 50 and 83% at 60-110 Gy. The risk for local failure increased by 8% per cm tumour diameter. With exclusive radiotherapy, the doses needed to provide local control rates similar to those obtained after tumorectomy and irradiation are 10 Gy higher for T1 (95% 5 year control) and 35 Gy higher for T2 (90% 5 year control).

Entities:  

Mesh:

Year:  1990        PMID: 2168190     DOI: 10.1016/0277-5379(90)90115-a

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

Review 1.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

2.  Patients' refusal of surgery strongly impairs breast cancer survival.

Authors:  Helena M Verkooijen; Gérald M Fioretta; Elisabetta Rapiti; Hervé Bonnefoi; Georges Vlastos; John Kurtz; Peter Schaefer; André-Pascal Sappino; Hyma Schubert; Christine Bouchardy
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

3.  Definitive single fraction stereotactic ablative radiotherapy for inoperable early-stage breast cancer: A case report.

Authors:  Manasa Veluvolu; Mausam Patel; Ganesh Narayanasamy; Thomas Kim
Journal:  Rep Pract Oncol Radiother       Date:  2020-07-11

4.  [Preoperative irradiation and interstitial radiotherapy-hyperthermia boost in breast tumors > or = 3 cm. The Düsseldorf experience].

Authors:  K A Hartmann; W Audretsch; U M Carl; S Gripp; C Kolotas; K Muskalla; M Rezai; T Schnabel; I Waap; N Zamboglou; G Schmitt
Journal:  Strahlenther Onkol       Date:  1997-10       Impact factor: 3.621

5.  Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases.

Authors:  Romuald Le Scodan; David Ali; Denise Stevens
Journal:  BMC Cancer       Date:  2010-11-17       Impact factor: 4.430

Review 6.  Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer.

Authors:  Tamara Shenkier; Lorna Weir; Mark Levine; Ivo Olivotto; Timothy Whelan; Leonard Reyno
Journal:  CMAJ       Date:  2004-03-16       Impact factor: 8.262

7.  Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol.

Authors:  R K Charaghvandi; B van Asselen; M E P Philippens; H M Verkooijen; C H van Gils; P J van Diest; R M Pijnappel; M G G Hobbelink; A J Witkamp; T van Dalen; E van der Wall; T C van Heijst; R Koelemij; M van Vulpen; H J G D van den Bongard
Journal:  BMC Cancer       Date:  2017-03-09       Impact factor: 4.430

8.  Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis.

Authors:  D Boyce-Fappiano; I Bedrosian; Y Shen; H Lin; O Gjyshi; A Yoder; S F Shaitelman; W A Woodward
Journal:  NPJ Breast Cancer       Date:  2021-07-05

9.  DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy.

Authors:  H Beerman; B A Bonsing; M J van de Vijver; J Hermans; P M Kluin; R J Caspers; C J van de Velde; C J Cornelisse
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

Review 10.  Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer.

Authors:  Aisling Barry; Anthony Fyles
Journal:  Int J Breast Cancer       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.